684 related articles for article (PubMed ID: 8922878)
1. The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential.
Fuhrmann U; Krattenmacher R; Slater EP; Fritzemeier KH
Contraception; 1996 Oct; 54(4):243-51. PubMed ID: 8922878
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the novel progestin gestodene by receptor binding studies and transactivation assays.
Fuhrmann U; Slater EP; Fritzemeier KH
Contraception; 1995 Jan; 51(1):45-52. PubMed ID: 7750284
[TBL] [Abstract][Full Text] [Related]
3. Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity.
Muhn P; Fuhrmann U; Fritzemeier KH; Krattenmacher R; Schillinger E
Ann N Y Acad Sci; 1995 Jun; 761():311-35. PubMed ID: 7625729
[TBL] [Abstract][Full Text] [Related]
4. Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity. Pharmacological characterization in animal models.
Muhn P; Krattenmacher R; Beier S; Elger W; Schillinger E
Contraception; 1995 Feb; 51(2):99-110. PubMed ID: 7750297
[TBL] [Abstract][Full Text] [Related]
5. The pharmacological profile of a novel norpregnance progestin (trimegestone).
Philibert D; Bouchoux F; Degryse M; Lecaque D; Petit F; Gaillard M
Gynecol Endocrinol; 1999 Oct; 13(5):316-26. PubMed ID: 10599548
[TBL] [Abstract][Full Text] [Related]
6. Nestorone: a progestin with a unique pharmacological profile.
Kumar N; Koide SS; Tsong Y; Sundaram K
Steroids; 2000; 65(10-11):629-36. PubMed ID: 11108869
[TBL] [Abstract][Full Text] [Related]
7. Conception and pharmacodynamic profile of drospirenone.
Elger W; Beier S; Pollow K; Garfield R; Shi SQ; Hillisch A
Steroids; 2003 Nov; 68(10-13):891-905. PubMed ID: 14667981
[TBL] [Abstract][Full Text] [Related]
8. Steroid receptor profiling of vinclozolin and its primary metabolites.
Molina-Molina JM; Hillenweck A; Jouanin I; Zalko D; Cravedi JP; Fernández MF; Pillon A; Nicolas JC; Olea N; Balaguer P
Toxicol Appl Pharmacol; 2006 Oct; 216(1):44-54. PubMed ID: 16750840
[TBL] [Abstract][Full Text] [Related]
9. In vitro characterization of trimegestone: a new potent and selective progestin.
Zhang Z; Lundeen SG; Zhu Y; Carver JM; Winneker RC
Steroids; 2000; 65(10-11):637-43. PubMed ID: 11108870
[TBL] [Abstract][Full Text] [Related]
10. Hormonal properties of norethisterone, 7alpha-methyl-norethisterone and their derivatives.
Schoonen WG; Deckers GH; de Gooijer ME; de Ries R; Kloosterboer HJ
J Steroid Biochem Mol Biol; 2000 Nov; 74(4):213-22. PubMed ID: 11162927
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of different progestogens: the special case of drospirenone.
Sitruk-Ware R
Climacteric; 2005 Oct; 8 Suppl 3():4-12. PubMed ID: 16203650
[TBL] [Abstract][Full Text] [Related]
12. Dihydrospirorenone (ZK30595): a novel synthetic progestagen--characterization of binding to different receptor proteins.
Pollow K; Juchem M; Elger W; Jacobi N; Hoffmann G; Möbus V
Contraception; 1992 Dec; 46(6):561-74. PubMed ID: 1493716
[TBL] [Abstract][Full Text] [Related]
13. Binding of a contraceptive progestogen ORG 2969 and its metabolites to receptor proteins and human sex hormone binding globulin.
Bergink EW; Hamburger AD; de Jager E; van der Vies J
J Steroid Biochem; 1981 Feb; 14(2):175-83. PubMed ID: 6451769
[TBL] [Abstract][Full Text] [Related]
14. 5alpha-reduction of norethisterone enhances its binding affinity for androgen receptors but diminishes its androgenic potency.
Lemus AE; Enríquez J; García GA; Grillasca I; Pérez-Palacios G
J Steroid Biochem Mol Biol; 1997 Jan; 60(1-2):121-9. PubMed ID: 9182866
[TBL] [Abstract][Full Text] [Related]
15. Demonstration of steroid hormone receptors and steroid action in primary cultures of rat glial cells.
Jung-Testas I; Renoir M; Bugnard H; Greene GL; Baulieu EE
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):621-31. PubMed ID: 1562533
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological effect of halogen substituted phenyl acetic acid derivatives of progesterone as potent progesterone receptor antagonists.
Cabeza M; Bratoeff E; Gómez G; Heuze I; Rojas A; Ochoa M; Palomino MA; Revilla C
J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):232-9. PubMed ID: 18625316
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of action of bolandiol (19-nortestosterone-3beta,17beta-diol), a unique anabolic steroid with androgenic, estrogenic, and progestational activities.
Attardi BJ; Page ST; Hild SA; Coss CC; Matsumoto AM
J Steroid Biochem Mol Biol; 2010 Feb; 118(3):151-61. PubMed ID: 19941958
[TBL] [Abstract][Full Text] [Related]
18. Drospirenone: pharmacology and pharmacokinetics of a unique progestogen.
Krattenmacher R
Contraception; 2000 Jul; 62(1):29-38. PubMed ID: 11024226
[TBL] [Abstract][Full Text] [Related]
19. Danazol binding to steroid receptors in human uterine endometrium.
Tamaya T; Wada K; Fujimoto J; Yamada T; Okada H
Fertil Steril; 1984 May; 41(5):732-5. PubMed ID: 6714450
[TBL] [Abstract][Full Text] [Related]
20. Preclinical evaluation of norgestimate, a progestin with minimal androgenic activity.
Phillips A; Hahn DW; McGuire JL
Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1191-6. PubMed ID: 1415445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
